Search results
Aimin Xu is currently a Chair Professor jointly appointed by the Department of Medicine and the Department of Pharmacology & Pharmacy, and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Professor Aimin Xu and his research associates Research Interests Obesity is a major risk factor of type 2 diabetes (T2DM), insulin resistance and cardiovascular diseases (CVDs).
Our primary research interest is to investigate the role of adipokines in the pathogenesis of obesity-related insulin resistance, systemic inflammation, T2DM and vascular dysfunctions in animal models and human subjects.
Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. AWK Tso, A Xu, PC Sham, NMS Wat, Y Wang, CHY Fong, BMY Cheung, ...
Curriculum Vitae-Aimin Xu. A: PERSONAL PROFILE . Telephone Number: (852) 39179754 . Fax number: (852) 28162095; Email address: amxu@hkucc.hku.hk. Contact address: Dept of Medicine, The University of Hong Kong . L8-40, 21 Sassoon Road, Pokfulam, Hong Kong . Personal website: http://www.pharma.hku.hk/pharma/staffweb/DrAiminXu/index.php
Aimin XU | Cited by 36,452 | of The University of Hong Kong, Hong Kong (HKU) | Read 711 publications | Contact Aimin XU
Professor Xu focuses on basic, clinical and translational research on obesity, diabetes and cardiovascular complications. He discovered the bioactive form of the anti-diabetic hormone adiponectin, and uncovered the potential of adiponectin in protection against obesity-related fatty liver and vascular diseases.
